Receives Orphan Drug

Related by string. * RECEIVES . receives . RECEIVE . re ceive : RECEIVE AN E MAIL . Iron Consulting receives . Parents Receive Graphic . Receive mediabistro.com s / orphaned . Orphaned . orphans : Little Orphan Annie . widows orphans . Swedish Orphan Biovitrum / DRUG . Drugs . drugs : Prescription Drug User Fee . Drug Task Force . Drug Enforcement Administration * Receives Orphan Drug Designation *

Related by context. Frequent words. (Click for all words.) 80 Presents Positive 79 Completes Enrollment 78 Drug Candidate 77 Patient Enrollment 77 FDA Accepts 77 Clinical Trial Results 76 FDA Clears 75 Announces Initiation 75 Preclinical Data 75 Patent Covering 74 Initiates Phase 74 Pivotal Phase III 74 Phase III Clinical Trial 74 FDA Orphan Drug 73 RNAi Therapeutics 73 Small Molecule 72 Receives FDA Clearance 72 Initiate Phase 72 Inc Therapeutic Competitors 72 Positive Opinion 72 Receives Patent 72 Phase III Trial 72 Pivotal Trial 71 Generic Version 71 Reports Positive 71 Study Demonstrates 71 Receives Positive 71 Announces Publication 71 Pivotal Phase 70 Panzem R 70 Announces Presentation 70 Shows Promise 70 Recombinant Human 70 Achieves Milestone 70 Kuvan R 70 Announces Positive 70 Chronic Hepatitis C 69 Monoclonal Antibody 69 Significantly Reduces 69 FDA Clearance 69 Orphan Drug status 69 FDA Approves 69 R bortezomib 69 refractory chronic lymphocytic 68 Entereg R 68 R sorafenib tablets 68 Patent Issued 68 Inc. Nasdaq IMGN 68 Regains Compliance With 68 Epratuzumab 68 Attains Gold Certified Partner 68 Well Tolerated 68 submitted Biologics License 68 Low Dose 67 Secures Additional 67 Awarded Patent 67 Reduces Risk 67 Pulmonary Arterial Hypertension 67 Regains Compliance 67 Announces Issuance 67 Q3 Loss Narrows 67 Q2 Loss Narrows 67 Reconfirms 67 Q3 Loss Widens 67 Anti Inflammatory 67 Vertex Pharmaceuticals Announces 67 Cancer Vaccines 67 Exploit collaboration 67 Idera Pharmaceuticals 67 Announces Additions 67 Metastatic Melanoma 67 granted Orphan Drug 67 k Clearance 67 Atopic Dermatitis 67 Acquires Exclusive 67 Prostate Cancer Patients 67 Updates Guidance 67 THERAPEUTICS 67 Pirfenidone 67 II Clinical Trial 67 CHEAP ONLINE PHARMACY LOW 66 Orphan Drug designation 66 Application MAA 66 Updates Shareholders 66 Commercialize 66 Announces Successful Completion 66 Provides Guidance 66 Receives Regulatory 66 Patients Treated 66 Orphan Drug Status 66 Q1 Loss Narrows 66 fibrosis IPF 66 Exclusive License 66 Inhibits 66 Receives CE 66 Drug Resistant 66 Fibrocell Science Inc. 66 Announce Collaboration 66 Benign Prostatic Hyperplasia 66 Overactive Bladder 66 Explore Strategic Alternatives

Back to home page